What's New
Re-invitation of applications under PLI Scheme for Bulk Drugs (Round-IV) for eligible product Vitamin B1 thru Chemical Synthesis Route. Refer Scheme & Guidelines Section for detailed notice. Last date of receipt of applications is 24th August 2022.
Home
(current)
About Us
DoP
About PMA
Scheme & Guidelines
Registration
Contact Us
For any queries, Please contact at bdpli[at]ifciltd[dot]com and pharma-bureau[at]gov[dot]in
Login
Applicant Registration
Applicant Details
Name of the Applicant
Business Constitution
Please choose..
Proprietary Firm
Partnership Firm
Limited Liability Partnership
Company
PAN
Please note that the user will login with the
PAN
as username.
CIN / LLPIN
(Applicable for Company / LLP)
Corporate Office Address
City
State
Pincode
Are you an existing manufacturer in Pharma Sector in India or Outside India?
Please choose..
Yes
No
If Yes, give brief description about existing business
(Min 300 Characters)
(Special characters not allowed)
Are you planning to set-up a Greenfield project for manufacturing of KSMs / DIs / APIs covered under the Scheme?
Please choose..
Yes
No
If Yes, brief description of about Applicant
(Min 300 Characters)
(Special characters not allowed)
Eligible product for which application is being filed
In terms of clause 7.3 of the Scheme Guidelines, an applicant may apply for more than one eligible product.
Applicant can select more than one product from the dropdown below.
Eligible Product
Target Segment
D. Other Chemical Synthesis based KSMs/ Drug Intermediates/ APIs
Authorized Person Details
Name:
Email:
E-mail will be verified after registration
Address
Confirm Password:
Designation
Mobile:
Mobile will be verified after registration
Password:
I have read the Scheme Notification and relevant Guidelines and M/s
is eligible to apply under the Scheme.
Register
Reset
